Natural History of Coronary Atherosclerosis
NASCENT
1 other identifier
observational
125
1 country
1
Brief Summary
The present study sought to explore the predictive value of radial wall strain (RWS, derived solely from angiograms) for coronary artery lesion progression compared with lesion vulnerability assessed by optical coherence tomography (OCT). The lesion progression at 1 year was defined as an increase of ≥20% in diameter stenosis based on quantitative coronary angiography (QCA) evaluation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedStudy Start
First participant enrolled
July 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedNovember 6, 2024
November 1, 2024
12 months
September 3, 2023
November 4, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Lesion progression assessed by QCA
Defined as an increase of ≥20% in diameter stenosis based on QCA evaluation
1 year
Secondary Outcomes (13)
Incidence of major adverse cardiac events (MACE)
1 year, 2 years, 3 years
Incidence of all-cause death
1 year, 2 years, 3 years
Incidence of new myocardial infarction
1 year, 2 years, 3 years
Incidence of unplanned revascularization
1 year, 2 years, 3 years
Incidence of stent thrombosis
1 year, 2 years, 3 years
- +8 more secondary outcomes
Eligibility Criteria
Adult study participants with acute myocardial infarction complicated by multi-vessel coronary artery diseases within 45 days.
You may qualify if:
- Age ≥18 years
- Acute myocardial infarction ≤ 45 days
- Planned coronary angiography examination or potential interventional treatment
- The presence of at least 1 non-flow-restricting lesion (visually estimated diameter stenosis: 30%-80%; QFR \> 0.80) in any non-infarct related artery with RVD ≥2.5 mm by visual assessment
You may not qualify if:
- Cardiogenic shock
- Pregnant or woman of child-bearing potential
- Life expectancy less than 1 year for non-cardiac causes
- Unable to tolerate contrast agents or anticoagulant/antiplatelet therapy
- Prior CABG or planned CABG
- Poor angiographic image quality precluding vessel contour detection or with suboptimal contrast opacification, branch ostium cannot be shown clearly, severe overlap in the stenosed segment or severe tortuosity of any interrogated vessel deemed not amenable to QFR or RWS measurement
- An interrogated lesion require surgical bypass grafting
- Unable to judge culprit lesion or infarct-related artery according to current evidence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lei Song
Beijing, 100037, China
Related Publications (1)
Jiang Y, Sun Z, Yu B, Liu W, Gao H, Li J, Jin Z, Yu H, Zheng B, Guan C, Zhang H, Zhang Y, Gao L, Cui C, Song Y, Xu J, Dou K, Yang W, Qian J, Wu Y, Song L. Natural history of coronary atherosclerosis based on multimodal imaging and physiological fusion techniques: study protocol and rationale for the NASCENT study. BMJ Open. 2025 Oct 23;15(10):e105796. doi: 10.1136/bmjopen-2025-105796.
PMID: 41130689DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Lei Song, MD
Chinese Academy of Medical Sciences, Fuwai Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the Coronary Heart Disease Ward, First Section
Study Record Dates
First Submitted
September 3, 2023
First Posted
September 15, 2023
Study Start
July 7, 2024
Primary Completion
June 30, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
November 6, 2024
Record last verified: 2024-11